Indivior Pharmaceuticals (NASDAQ: INDV) net income
Indivior Pharmaceuticals reported a net profit of $210.0m for fiscal 2025, 2,900.0% more than in fiscal 2024 ($7.0m). Its net margin was 16.9%. Earnings per share were $1.68.
Fiscal 2025 is the highest of the 3 fiscal years on record for Indivior Pharmaceuticals. It reported a loss in 1 of those 3 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $210.0m | +2,900.0% | 16.9% | $1.68 |
| 2024 | $7.0m | — | 0.6% | $0.05 |
| 2023 | −$126.0m | — | −11.5% | −$0.94 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Indivior Pharmaceuticals net income compared with its sector
By net income for its latest fiscal year, Indivior Pharmaceuticals ranks 86th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Indivior Pharmaceuticals, 16.9%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 84th | Aveanna Healthcare | $225.0m | 9.2% |
| 85th | HealthEquity | $215.2m | 16.4% |
| 86th | Indivior Pharmaceuticals | $210.0m | 16.9% |
| 87th | Option Care Health | $207.6m | 3.7% |
| 88th | Krystal Biotech | $204.8m | 52.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Indivior Pharmaceuticals
- How much did Indivior Pharmaceuticals earn in fiscal 2025?
- Indivior Pharmaceuticals reported a net profit of $210.0m for fiscal 2025. In fiscal 2024 it reported a net profit of $7.0m.
- What are the earnings per share of Indivior Pharmaceuticals?
- They were $1.68 in fiscal 2025, compared with $0.05 in fiscal 2024.
- What is the net margin of Indivior Pharmaceuticals?
- In fiscal 2025 its net profit was 16.9% of its revenue.
- What was the most profitable year for Indivior Pharmaceuticals?
- Of its last 3 fiscal years, fiscal 2025, with $210.0m.
- Where does Indivior Pharmaceuticals rank in its sector by net income?
- It ranks 86th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Indivior Pharmaceuticals come from?
- From the annual report (Form 10-K) that Indivior Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Indivior Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on Indivior Pharmaceuticals: the Indivior Pharmaceuticals page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.